Ilango Subramanian
38Patents
1h-index
8Co-inventors
39Inventor score
Filing activity: Feb 14, 2020 → Mar 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11298315B2 | Triamcinolone and moxifloxacin compositions | Human Necessities | 3 | Active |
| US11400100B2 | Effective benzalkonium chloride-free bimatoprost ophthalmic compositions | Human Necessities | 1 | Active |
| US11696910B2 | Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof | Human Necessities | 1 | Active |
| US11564931B2 | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties | Human Necessities | 1 | Active |
| US11433115B2 | Glycopeptide antibiotics liquid formulations and methods and uses thereof | Human Necessities | 1 | Active |
| US11478492B2 | Tobramycin compound conjugate formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US12097178B2 | Methods of efficiently treating vitamin C deficiency-related diseases and other conditions | Human Necessities | 0 | Active |
| US11382863B2 | Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid | Human Necessities | 0 | Active |
| US12343373B2 | Glycopeptide antibiotics liquid formulations and methods and uses thereof | Human Necessities | 0 | Active |
| US11344566B2 | Tobramycin compound conjugates and derivative compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11517522B2 | Aprepitant ready-to-use injection emulsion compositions | Human Necessities | 0 | Active |
| US12102632B2 | Quinolone dispersions | Human Necessities | 0 | Active |
| US11969410B2 | Low pH pilocarpine and brimonidine compound formulations and related methods | Human Necessities | 0 | Active |
| US11793789B2 | Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrine | Human Necessities | 0 | Active |
| US11850249B2 | Methods of efficiently reducing intraocular pressure | Human Necessities | 0 | Active |
| US11471403B2 | Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use | Human Necessities | 0 | Active |
| US11510930B2 | Gatifloxacin, prednisolone, and bromfenac compositions and methods | Human Necessities | 0 | Active |
| US12016855B2 | Prednisolone and moxifloxacin compositions and methods | Human Necessities | 0 | Active |
| US11786538B2 | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties | Human Necessities | 0 | Active |
| US12029729B2 | Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof | Human Necessities | 0 | Active |
| US11883382B2 | Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereof | Human Necessities | 0 | Active |
| US11478491B2 | Tobramycin compound-copolymer conjugates and derivative compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11857538B2 | Stable pilocarpine formulations with modified buffer characteristics and related methods | Human Necessities | 0 | Active |
| US11857539B2 | Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methods | Human Necessities | 0 | Active |
| US11523987B2 | Trimcinolone and moxifloxacin methods | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.